Fentanyl Citrate
Product Images NDC 0093-7866

26 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Fentanyl Citrate (NDC 0093-7866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Image 1
Flowchart illustrating the titration process for Oral Transmucosal Fentanyl Citrate, starting at 200 mcg with instructions on dosage intervals, dose adjustments based on relief, and available dosage strengths ranging from 200 to 1600 mcg. Includes guidelines on maximum units per episode and timing between doses.*
FDA Label Image

Mg-figure-1 (Image 10)

Mg-figure-1 (Image 10)
An instructional line drawing illustrating a child-resistant closure on a vial or bottle. The image shows arrows indicating the direction to push down and turn the cap to open it. This is commonly used for medication containers, such as those for fentanyl citrate.*
FDA Label Image

Mg-figure-2 (Image 11)

Mg-figure-2 (Image 11)
An instructional line drawing showing hands opening or closing a cabinet or storage box with a door that has a latch or lock mechanism. The image likely illustrates safe storage or handling procedures.*
FDA Label Image

Mg-figure-3 (Image 12)

Mg-figure-3 (Image 12)
An instructional illustration showing two-step hand actions: the first step depicts scissors cutting a patch, and the second step shows hands handling or applying the patch. This is likely related to the use or preparation of a Fentanyl Citrate transdermal patch by Teva Pharmaceuticals USA, Inc.*
FDA Label Image

Mg-figure-4 (Image 13)

Mg-figure-4 (Image 13)
An instructional illustration showing a hand holding a medicine applicator with labeled parts: 'Medicine' and 'Handle.' The second part of the illustration depicts a hand positioning the applicator inside a toilet bowl, indicating the method of disposal or use of the applicator tool.*
FDA Label Image

Mg-figure-5 (Image 14)

Mg-figure-5 (Image 14)
An instructional line drawing depicting a hand placing or removing a bag inside a container or bin, demonstrating a step in a process likely related to proper disposal or handling.*
FDA Label Image

Mg-figure-6 (Image 15)

Mg-figure-6 (Image 15)
An instructional diagram showing a hand flushing a toilet twice. The toilet seat is raised, and the flush lever is pressed, with text indicating "Flush 2 Times." This illustration likely instructs on proper disposal or flushing procedure.*
FDA Label Image

Mg-figure-7 (Image 16)

Mg-figure-7 (Image 16)
The image shows a side view of a white rectangular plastic blister tray designed to hold medication tablets or capsules. There is no visible text or labeling on this side of the packaging. The tray appears to be a component of pharmaceutical packaging, likely used for the product Fentanyl Citrate by Teva Pharmaceuticals USA, Inc.*
FDA Label Image

Mg-figure-8a-8b (Image 17)

Mg-figure-8a-8b (Image 17)
An instructional diagram showing hands manipulating a device, likely demonstrating how to open or use a Fentanyl Citrate delivery system or applicator. The first panel shows pulling apart components, and the second shows pressing or activating the device.*
FDA Label Image

Mg-figure-9a-9b (Image 18)

Mg-figure-9a-9b (Image 18)
An instructional illustration showing a hand holding a medical applicator device labeled with parts: 'Handle' and 'Medicine' at the tip. The image demonstrates how to hold the device by its handle to access the medicine.*
FDA Label Image

Mg-figure-10 (Image 19)

Mg-figure-10 (Image 19)
An instructional illustration showing a person placing a medication strip on their tongue. The image highlights the motion of the head, suggesting an up-and-down movement, likely demonstrating the proper method for using a sublingual or buccal film dosage form.*
FDA Label Image

Image 2

Image 2
Chemical structure diagram showing the molecular structure of fentanyl citrate. The diagram includes ring structures and functional groups consistent with fentanyl and citrate molecules.*
FDA Label Image

Mg-figure-11 (Image 20)

Mg-figure-11 (Image 20)
An instructional diagram showing hands opening a bottle of Fentanyl Citrate. One hand holds the bottle, while the other hand is lifting or removing the cap. The image depicts a step in accessing the medication inside the container.*
FDA Label Image

Mg-figure-12 (Image 21)

Mg-figure-12 (Image 21)
Box packaging label for Oral Transmucosal Fentanyl Citrate (OTFC) equivalent to 200 mcg fentanyl base, containing 30 units. The product is labeled by Teva Pharmaceuticals USA, Inc. The label includes usage warnings and storage information, emphasizing careful handling and safety precautions.*
FDA Label Image

Mg-figure-13a-13b (Image 22)

Mg-figure-13a-13b (Image 22)
The image shows the packaging label for Fentanyl Citrate oral transmuscosal system (OTFC) by Teva Pharmaceuticals USA, Inc. The label indicates a strength equivalent to 400 mcg fentanyl base, with 30 units per box. The packaging includes instructions for use, warnings, and the Teva logo, displaying information in a structured box layout.*
FDA Label Image

Mg-figure-14 (Image 23)

Mg-figure-14 (Image 23)
Packaging label for Oral Transmucosal Fentanyl Citrate (OTFC) by Teva Pharmaceuticals USA, Inc., equivalent to 600 mcg fentanyl base. The label indicates a 30-unit carton and includes dosage form and strength information prominently in orange and white text blocks. Warnings and usage information are also present.*
FDA Label Image

Mg-figure-15 (Image 24)

Mg-figure-15 (Image 24)
Packaging label for Oral Transmucosal Fentanyl Citrate (OTFC) by Teva Pharmaceuticals USA, Inc. The label states the product is equivalent to 800 mcg fentanyl base and contains 30 units. The label includes usage warnings, product information, and barcodes on a purple and white background.*
FDA Label Image

Mg-figure-16 (Image 25)

Mg-figure-16 (Image 25)
Packaging label for Oral Transmucosal Fentanyl Citrate (OTFC) by Teva Pharmaceuticals USA, Inc. The label states it is equivalent to 1200 mcg fentanyl base and contains 30 units. It provides drug warnings, usage instructions, barcodes, and the product's legal and manufacturing details. The label is printed in green and white with detailed regulatory and safety information.*
FDA Label Image

Oral Transmucosal Fentanyl Citrate (otfc) 200 Mcg Cii, 30s Carton (Image 26)

Oral Transmucosal Fentanyl Citrate (otfc) 200 Mcg Cii, 30s Carton (Image 26)
Packaging label for Oral Transmucosal Fentanyl Citrate (OTFC) by Teva Pharmaceuticals USA, Inc. The label indicates a strength equivalent to 1600 mcg fentanyl base and includes a 30 units count. The label features dosing and safety information, barcodes, and various handling instructions on a folded carton.*
FDA Label Image

Image 3

Image 3
A pharmacokinetic line graph depicting the mean serum fentanyl concentration (ng/mL) over time (minutes) for four different fentanyl doses: 200 mcg, 400 mcg, 800 mcg, and 1600 mcg. The graph shows concentration decreasing over a 1440-minute period with distinct curves for each dose, illustrating higher concentrations and longer persistence with increasing doses.*
FDA Label Image

Image 4

Image 4
A line graph comparing pain relief scores over 60 minutes between OTFC (oral transmucosal fentanyl citrate) and placebo groups. The y-axis represents pain relief scores from none to complete, while the x-axis shows time in minutes. OTFC shows higher pain relief scores at all time points compared to placebo, with error bars indicating variability.*
FDA Label Image

Image 5

Image 5
An instructional line drawing demonstrating the correct method for reconnecting or removing a cable from a device port, showing a hand gripping a connector and inserting or withdrawing it from a rectangular socket.*
FDA Label Image

Image 6

Image 6
An illustration showing a waist pouch with a zipper closure. The pouch appears to be designed to be worn around the waist with an adjustable strap and buckle.*
FDA Label Image

Image 7

Image 7
Black and white line drawing of a vial with a stopper being pierced by a needle attached to a syringe. The vial has a hexagonal or faceted shape at the base. The illustration likely demonstrates how to access the medication inside the vial.*
FDA Label Image

Image 8

Image 8
An instructional diagram showing a hand pressing a tube over a sink drain, with liquid flowing from the tube into the drain. The illustration appears to demonstrate a disposal method for the product Fentanyl Citrate.*
FDA Label Image

Image 9

Image 9
An instructional line drawing showing a person inserting a stick or applicator into a container. The image appears to demonstrate a step in the preparation or use of a product, possibly related to Fentanyl Citrate, with both hands involved in the process.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.